Recently, endovascular treatment of coil embolisation has been widely used for obliterating cerebral aneurysms. However, the process of endothelial cell growth within aneurysms to prevent aneurysmal rupture associated with endo vascular coil embolisation remains unclear. Fourteen aneurysms were produced in seven matured swine and embolised with Guglielmi Detachable coils (GDCs). The aneurysms were resected either immediately or three weeks after coil embolisation, and subjected to histological and scanning electron microscopic examinations. Blood coagulation factor XIII was administered in four animals on the day of embolisation and on the following four days. These aneurysms were also resected three weeks after the embolisation and investigated histologically. Marked fibroblast proliferation and growth of endothelial cells on the intraluminal surface of the coil were observed more often in the group administered factor XIII than in those not given factor XIII. These results suggest that administration of factor XIII may contribute to more effective aneurysm obliteration during coil embolisation.
Introduction
Although surgical clipping remains the gold standard for treatment of cerebral aneurysms, there is a growing trend toward endovascular treatment of those aneurysms. In particular, coil embolisation of the aneurysms has been reported to be useful in patients with surgically inaccessible aneurysms and those with poor surgical risks 1,2,3,16. Compared with conventional aneurysmal clipping, however, several problems still have to be overcome for effective use of coil embolisation 3. Aneurysmal thrombosis following coil embolisation may influence the patient's long-term prognosis, but the risk of late recanalization remains a significant problem with this technique 1-3,7,20,25,29. The process of endothelial cell growth within aneurysms may contribute to prevent such recanalization. Recently, Kang et Al reported that treatment by factor XIII, a wound-healing accelerator, produced endothelial cell growth in the lumen of an experimental aneurysm 11. Here we present our experience with Guglielmi Detachable Coils (GDCs) embolisation of experimental aneurysms in swine using factor XIII and evaluate endothelial cell proliferation on the intraluminal surface of the inserted coil using scanning electron microscopy.
Material and Methods
All animal experiments were conducted in accordance with policies set by the Kyorin University School of Medicine Animal Research Committee and National Institutes of Health guidelines. Eight mature swine (weighing 25-30 kg) were pre-medicated with atropine sulfate (0.02 mg/kg, i.m.) and ketamine (20 mg/kg, i.m.), intubated under pre-medication with 5 % halothane and general anesthesia was maintained with 2-4% halothane and oxygen. Intravenous infusion of heparin-containing physiologic saline and monitoring of respiration/ECG were conducted during the anesthetized period.
A median incision of the neck was made to expose the external carotid artery where it branches from the common carotid artery. The external carotid artery approximately 1 cm distal to the carotid bifurcation and the ascending pharyngeal artery were ligated with a 2-0 silk suture to obtain experimental aneurysms. A 5 Fr sheath was placed in the right femoral artery and selective common carotid arteriography using a 5 Fr catheter confirmed formation of experimental aneurysms. A micro catheter was inserted through 5Fr catheter and placed in an aneurysm, which was then embolised with GD-Cs (2 mm x 8 cm, 3 mm x 8 cm) under the guidance of a fluoroscope. In all aneurysms, total or subtotal angiographical obliteration was confirmed on the fluoroscope. The embolised aneurysms were resected either immediately (three aneurysms) or three weeks after the treatment (11 aneurysms). Four animals (eight aneurysms) undergoing coiling of experimentally-induced aneurysms were given blood coagulation factor XIII (Fibrogammin P: Aventis Pharma Ltd., Tokyo, Japan) intravenously, 3 units per day for five days beginning immediately after the embolisation. The eight aneurysms were resected three weeks after the treatment. After removal of experimental aneurysms, all eight animals were sacrificed by an injection of a fatal dose of ketamine.
The aneurysms containing GDCs were fixed in 1.25% glutaraldehyde and subjected to histological examination and scanning electron microscopy to investigate the modification of the surface of inserted GDCs with respect to infiltration of endothelial cells and/or fibroblasts. The findings were evaluated blindly by two investigators.
Results
Histologic and electron microscopic analyses demonstrated that the aneurysms removed immediately after embolisation in the absence of factor XIII contained blood constituent on the coil surfaces, without ingrowth of fibroblasts or endothelial cells.
In the aneurysms resected three weeks after embolisation in the absence of factor XIII, a moderate number of fibroblasts were recruited to the intra-aneurysmal cavity and endothelial cells partially covered the coil surface. In contrast, in aneurysms resected three weeks after embolisation in the presence of factor XIII, there were multiple layers of fibroblasts overlying the coils and endothelial cells were in continuity with the endothelial cells at the orifice of the aneurysms (figure lA, lB).
Intra-aneurysmal recruitment and growth of fibroblasts and endothelial cells were significantly more apparent in the aneurysms treated with factor XIII compared to those that did not receive factor XIII.
Discussion
Recently, endovascular coil embolisation has become a commonly employed treatment for intracranial aneurysms. Guglielmi et Al developed a retrievable embolisation coil that is detached within an aneurysm by the application of an electrical current 1,2. A minimal electric current sent to an aneurysm may accelerate intra-aneurysm thrombosis because a positively charged platinum coil attracts negatively charged blood cells and fibrinogen 1,2,19. GDCs have been increasingly used because of their relative safety, effectiveness, and simplicity of use 1-3. However, long-term clinical outcome of treatment cerebral aneurysm with GDCs is still unknown. Guglielmi et Al reported that the mortality and morbidity of 42 cases treated GDCs embolisation were 4.8%(two cases) and 2.4 % (one case), respectively 3 . Venula et Al reported overall rates of 8.9% morbidity and 6.2% mortality in 403 acute ruptured aneurysms embolised with GDC technique 29. Hayakawa et al. reported that 18 aneurysms (25%) exhibited progressing thorombosis, 19 aneurysms (26%) remained unchanged, and 36 (49%) displayed recanalization on follow-up angiography in 455 aneurysms treated with GDCs 25. These reports suggest that coil embolisation is an effective and less invasive method to prevent acute rebleeding from aneurysms, but the possibility of delayed recanalization remains as significant problem with this technique. Early development of tough membrane may contribute significantly to prevent such recanalization and bleeding from treated aneurysm, but the efficacy of GDCs in the promotion of thrombosis, proliferation of fibroblasts, and growth of vascular endothelial cells have not yet been definitively assessed 4 -7 • Investigation of the processes regulating thrombosis, the proliferation of fibroblasts, and the growth of endothelial cells occurring in an embolised aneurysm would provide further support for the application and improvement of the endovascular approach for treatment of aneurysms. Histological changes in the endolu-minal surface of aneurysms after the endovascular treatment have been controversial. Some basic and clinical studies have shown that the surface of the aneurysmal lumen was covered with endothelial cells after treatment 5-7,2 1, 23-28 , whereas others have demonstrated that endothelial growth was not sufficient to produce thrombosis 4,19 . In Spetzger's study, histological investigation demonstrated that six months after coil embolisation with GDCs, a thin layer of granulation tissue covered the surface of the coil in only four cases of 17 experimentally induced aneurysms 26. Tenjin et Al reported histological changes in aneurysms experimentally treated with GDCs showing proceeding endothelialization two weeks after coil placement, and organizing aneurysm with media-like structure at three months 5. Mawad et Al revealed similar findings 6. In some autopsy cases, only a thin membrane was observed on the coil surface 23,28, whereas others were completely covered with new membrane isolating of parent vesse [24. The level and duration of thrombosis after embolisation are also poorly understood.
Blood coagulation factor XIII is important for haemostasis and wound healing. Factor XI-II bridges the fibrin molecules and rearranges the fibrin network, which accelerates the proliferation of fibroblasts. Factor XIII also promotes collagen synthesis in a wound and thereby plays an important role in wound healing B -lO • Kang et Al reported that treatment by factor XIII produced endothelial cell growth in the lumen of an experimental aneurysm 11. Histological investigation of en do luminal changes in experimentally produced aneurysms was evaluated histologically after treatment with proteincoated GDCs or a collagen-coated micro coil. When aneurysms were treated using coils with these coating materials, markedly increased proliferation of fibroblasts was observed, and thus thrombosis could be increased 12-18,22, In the present study, we used factor XIII in coil embolisation of experimentally induced aneurysms, resulting in marked proliferation of fibroblasts and growth of endothelial cells. These cells covered GDCs in the aneurysms three weeks after the procedure. In contrast, in the absence of Factor XIII, only a moderate and partial increase in the number of fibroblasts and endothelial cells were observed on the GDCs, suggesting that factor XIII may facilitate focal proliferation of fibroblasts as well as recruitment of endothelial cells to the inserted coils, which may lead to thrombus formation.
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Conclusions
Factor XIII accelerated the proliferation of fibroblasts and the growth of endothelial cells with coil embolisation treatment in the experimental aneurysm model. The intravenous administration of factor XIII after coil embolisation may promote more efficacious endovascular coil treatment of intracranial aneurysms. The use of factor XIII can be a powerful adjunct to coil embolisation, although further studies may still be needed.
